LondonResearchers tracked the same 40 brains twice.
Relapse is often read as a failure of will, and treatment access is rationed accordingly.
Repeat scans through abstinence let a model predict, per person, whether craving would rise or fall, not just describe group averages.
The authors call it a candidate biomarker, not yet a tool to allocate treatment.
Sources: Nature